Invesco’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-1,542,410
| Closed | -$30M | – | 3967 |
|
|
2018
Q1 | $30M | Sell |
1,542,410
-349,144
| -18% | -$6.85M | 0.01% | 966 |
|
|
2017
Q4 | $31.5M | Buy |
1,891,554
+153,037
| +9% | +$2.81M | 0.01% | 973 |
|
|
2017
Q3 | $35.3M | Buy |
1,738,517
+1,020,292
| +142% | +$19.5M | 0.01% | 922 |
|
|
2017
Q2 | $11.6M | Sell |
718,225
-2,204,267
| -75% | -$32.6M | ﹤0.01% | 1467 |
|
|
2017
Q1 | $37M | Sell |
2,922,492
-1,115,968
| -28% | -$13.5M | 0.01% | 931 |
|
|
2016
Q4 | $53.5M | Buy |
4,038,460
+170,314
| +4% | +$2.91M | 0.02% | 742 |
|
|
2016
Q3 | $91.7M | Buy |
3,868,146
+466,730
| +14% | +$12.5M | 0.03% | 537 |
|
|
2016
Q2 | $98M | Sell |
3,401,416
-46,547
| -1% | -$1.52M | 0.04% | 506 |
|
|
2016
Q1 | $110M | Sell |
3,447,963
-80,821
| -2% | -$2.84M | 0.04% | 454 |
|
|
2015
Q4 | $151M | Buy |
3,528,784
+388,764
| +12% | +$15.5M | 0.06% | 357 |
|
|
2015
Q3 | $111M | Buy |
3,140,020
+72,097
| +2% | +$3.25M | 0.05% | 450 |
|
|
2015
Q2 | $141M | Sell |
3,067,923
-265,689
| -8% | -$12.6M | 0.06% | 395 |
|
|
2015
Q1 | $156M | Buy |
3,333,612
+27,663
| +0.8% | +$1.1M | 0.06% | 386 |
|
|
2014
Q4 | $105M | Sell |
3,305,949
-269,645
| -8% | -$7.89M | 0.04% | 506 |
|
|
2014
Q3 | $84.8M | Buy |
3,575,594
+382,363
| +12% | +$9.79M | 0.03% | 557 |
|
|
2014
Q2 | $95.8M | Buy |
3,193,231
+1,536,557
| +93% | +$41.5M | 0.04% | 527 |
|
|
2014
Q1 | $43.8M | Buy |
1,656,674
+280,708
| +20% | +$7.02M | 0.02% | 847 |
|
|
2013
Q4 | $34.6M | Buy |
1,375,966
+114,680
| +9% | +$2.56M | 0.01% | 983 |
|
|
2013
Q3 | $25.8M | Buy |
1,261,286
+302,566
| +32% | +$6.25M | 0.01% | 1049 |
|
|
2013
Q2 | $19.1M | Buy |
+958,720
| New | +$17M | 0.01% | 1120 |
|
Invesco's IPXL Position: Q2 2018 in Review
Invesco sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 1,542,410 shares — an estimated $30M sold.
Invesco first reported a position in IPXL in Q2 2013 and held it in 20 quarters. The position peaked at $156M in Q1 2015. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.
- Invesco reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
- Invesco sold 1,542,410 Impax Laboratories, Inc. shares in Q2 2018, an estimated $30M.
- Invesco first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 20 quarters.
- Invesco's Impax Laboratories, Inc. position peaked at $156M in Q1 2015.
- 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.
Based on Invesco's 13F filing for Q2 2018, filed 14 Aug 2018.